Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05225038 · ClinicalTrials.gov registry record · NA
Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms
A NA study of Pancreatic Neoplasms and Periampullary Carcinoma, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT05225038 is a NA study of Pancreatic Neoplasms and Periampullary Carcinoma that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 23 participants, below the 601-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05225038, a NA study of Pancreatic Neoplasms and Periampullary Carcinoma, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for participants with Pancreatic and Periampullary Neoplasms
Conditions Studied
Interventions
- OTHER Exercise
- BEHAVIORAL Smoking Cessation
- DIETARY_SUPPLEMENT Nutritional
- BEHAVIORAL Behavioral Medicine
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-06-13 |
| Est. Completion | 2023-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05225038
The ClinicalTrials.gov registry entry for NCT05225038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 601-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (96% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pancreatic Neoplasms appearing as the primary indexed condition, and to 4 interventions - of which Exercise is the first listed.
NCT05225038 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05225038 about?
NCT05225038 is a clinical study titled "Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms". Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for participants with Pancreatic and Periampullary Neoplasms
What is the current status of trial NCT05225038?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-06-13. Estimated completion is 2023-10-30.
What conditions does trial NCT05225038 study?
This clinical trial studies the following conditions: Pancreatic Neoplasms, Periampullary Carcinoma.
What interventions are being tested in trial NCT05225038?
The interventions under investigation include: Exercise (OTHER), Smoking Cessation (BEHAVIORAL), Nutritional (DIETARY_SUPPLEMENT), Behavioral Medicine (BEHAVIORAL).
Who is sponsoring clinical trial NCT05225038?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05225038 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis
COMPLETED · NA
-
Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region
COMPLETED · NA
-
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
RECRUITING
-
Determining Individualized Cancer Therapy in Pancreatic Cancer
RECRUITING
-
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
RECRUITING · Phase 2
-
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.